HIGHLIGHTS
- What: The experiments focused on the interaction of 2`,3`-cGAMP with the immune system and its potential to modulate immune-mediated tumor suppression.
- Who: Zhanghao Huang from the The Second Hospital of Shandong University, China have published the research: PRKDC regulates cGAMP to enhance immune response in lung cancer treatment, in the Journal: (JOURNAL)
- How: Molecular docking results indicated that 2`3`cGAMP and SB505124 can interact with PRKDC binding_sites validating the results of machine-learning-based drug screening.
- Future: Future investigations need to focus on the role of PRKDC . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.